Literature DB >> 17461534

Acute Marchiafava-Bignami disease: diffusion-weighted MRI in cortical and callosal involvement.

Yon Kwon Ihn1, Seong Su Hwang, Young Ha Park.   

Abstract

Marchiafava-Bignami disease (MBD) is a fatal disorder characterized by demyelination of the corpus callosum. MRI, suggestive of corpus callosum demyelination with associated white matter involvement in both cerebral hemispheres, indicates a diagnosis of MBD. In this case, MR diffusion-weighted findings taken at an acute stage of MBD revealed lesions not only in the corpus callosum but also in the cerebral cortex. Lower apparent diffusion coefficient values of the corpus callosum and cortical lesions were associated with poor clinical outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17461534      PMCID: PMC2628118          DOI: 10.3349/ymj.2007.48.2.321

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  9 in total

1.  [A case of Marchiafava-Bignami disease demonstrated by MR diffusion-weighted image].

Authors:  T Inagaki; K Saito
Journal:  No To Shinkei       Date:  2000-07

2.  Acute Marchiafava-Bignami disease: MR findings in two patients.

Authors:  Andres Arbelaez; Adriana Pajon; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

3.  Marchiafava-Bignami disease: serial changes in corpus callosum on MRI.

Authors:  K H Chang; S H Cha; M H Han; S H Park; D L Nah; J H Hong
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

4.  Diffusion-weighted magnetic resonance imaging in Marchiafava-Bignami disease: follow-up studies.

Authors:  C Hlaihel; P-M Gonnaud; S Champin; H Rousset; V-A Tran-Minh; F Cotton
Journal:  Neuroradiology       Date:  2005-05-26       Impact factor: 2.804

5.  Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions.

Authors:  P Ménégon; I Sibon; C Pachai; J M Orgogozo; V Dousset
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

6.  Hemispheric disconnection syndrome with a "crossed avoiding" reaction in a case of Marchiafava-Bignami disease.

Authors:  B Lechevalier; J C Andersson; P Morin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-05       Impact factor: 10.154

7.  Wernicke encephalopathy with symmetric pericentral involvement: MR findings.

Authors:  M Yamashita; T Yamamoto
Journal:  J Comput Assist Tomogr       Date:  1995 Mar-Apr       Impact factor: 1.826

8.  Cortical involvement in Marchiafava-Bignami disease.

Authors:  Ken Johkura; Makoto Naito; Takayuki Naka
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

9.  Marchiafava-Bignami disease: magnetic resonance imaging findings in corpus callosum and subcortical white matter.

Authors:  Kentaro Kawarabuki; Takehiko Sakakibara; Makoto Hirai; Yuji Yoshioka; Yasumasa Yamamoto; Tarumi Yamaki
Journal:  Eur J Radiol       Date:  2003-11       Impact factor: 3.528

  9 in total
  5 in total

1.  Overreligious beliefs with neuropsychiatric manifestations in a young lady-Rule out Marchiafava-Bignami disease.

Authors:  Vijoy Kumar Jha; Dev Prakash Sharma; Vivek Sharda; Abhilasha Kumari
Journal:  Med J Armed Forces India       Date:  2019-04-15

Review 2.  Structural and microstructral imaging of the brain in alcohol use disorders.

Authors:  Natalie M Zahr
Journal:  Handb Clin Neurol       Date:  2014

Review 3.  Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases.

Authors:  Matti Hillbom; Pertti Saloheimo; Shinsuke Fujioka; Zbigniew K Wszolek; Seppo Juvela; Maurizio A Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-26       Impact factor: 10.154

Review 4.  Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.

Authors:  Natalie M Zahr; Adolf Pfefferbaum
Journal:  Alcohol Res       Date:  2017

5.  Clinical and radiological features of Marchiafava-Bignami disease.

Authors:  Xiaoyu Dong; Chaobo Bai; Jianfei Nao
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.